Product Details:
Minimum Order Quantity | 1 Bottle |
Packaging Size | Bottle |
Brand | Aprazer |
Composition | Soafenib 200mg |
Manufacturer | Aprazer |
Treatment | Cancer |
Prescription/Non prescription | Non prescription |
Form | Tablet |
Shelf life | More than 2 YEARS |
Sorafenib Tablets IP 200mg Tablets IP SORAFEKAST
Sorafekast 200mg is approved for the treatment of primary kidney cancer, advanced primary liver cancer and thyroid cancer.
Additional Information:
4.2/5
Rated by 67 Users